CI looks worth holding as Evernorth growth, expanding pharmacy services, cheap valuation and shareholder returns support its ...

If you are wondering whether Novavax at around US$7.25 is a bargain or a value trap, you are not alone. This article focuses on what the current price really implies about the company. The stock has ...